Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 645 | 653 | 727 | 724 | 714 |
| Operating Income | -645 | -653 | -727 | -724 | -714 |
| Other Income | 4 | 5 | 11 | 8 | 2 |
| Pre-tax Income | -642 | -647 | -716 | -716 | -712 |
| Net Income Continuous | -642 | -647 | -716 | -716 | -712 |
| Net Income | $-642 | $-647 | $-716 | $-716 | $-712 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EBITDA(a) | $-513 | $-518 | $-592 | $-590 | $-581 |